Autolus Therapeutics plc (AUTL) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$41.68M*; Operating income -$43.84M; Depreciation and amortization $2.16M*.
- 2026-03-31: Basis Reported; EBITDA -$57.3M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$70.32M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$69.54M*; Operating income -$71.62M; Depreciation and amortization $2.08M*.
Complete source-backed ebitda history.
- Available history
- 2019-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$41.68M* | -$43.84M | $2.16M* | $45.69M | -91.22%* | $913.00K* | -$25.07M* | $20.47M | $27.90M | $41.16M | $465.00K |
|---|
| 2026-03-31 | Reported | -$57.3M | (m) | (m) | (m) | -218.57% | $2.69M | -$65.32M | $24.57M | $21.21M | $39.95M | $863.00K |
|---|
| 2025-12-31 | Reported | -$70.32M | (m) | (m) | (m) | -289.53% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$69.54M* | -$71.62M | $2.08M* | $21.19M | -328.12%* | $4.41M* | -$67.90M* | $28.64M | $27.89M | $36.28M | $532.00K |
|---|
| 2025-06-30 | Reported | -$59.13M* | -$61.22M | $2.08M* | $20.92M | -282.63%* | $7.28M* | -$72.78M* | $24.45M | $27.43M | $30.27M | $397.00K |
|---|
| 2025-03-31 | Reported | -$63.25M | (m) | (m) | (m) | -704.16% | $8.24M | -$75.56M | $17.95M | $26.73M | $29.54M | $2.23M |
|---|
| 2024-12-31 | Reported | -$73.95M | (m) | (m) | (m) | -254996.55% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$65.94M* | -$67.88M | $1.94M* | $0.00 | (m) | $9.59M* | -$76.74M* | $0.00 | $40.32M | $27.33M | $22.00K |
|---|
| 2024-06-30 | Reported | -$57.03M* | -$58.93M | $1.90M* | $0.00 | (m) | $841.00K* | -$51.08M* | $0.00 | $36.61M | $21.90M | $51.00K |
|---|
| 2024-03-31 | Reported | -$36.95M | (m) | (m) | (m) | -366.18% | $533.00K | -$40.51M | $0.00 | $30.67M | $18.18M | -$8.00K |
|---|
| 2023-12-31 | Reported | -$51.5M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$41.53M* | -$42.91M | $1.38M* | (m) | (m) | $1.50M* | -$40.19M* | (m) | $32.32M | (m) | -$21.00K |
|---|
| 2023-06-30 | Reported | -$42.87M* | -$44.38M | $1.51M* | (m) | (m) | $4.39M* | -$38.15M* | (m) | $33.23M | (m) | $40.00K |
|---|
| 2023-03-31 | Reported | -$37.25M | (m) | (m) | (m) | (m) | $3.62M | -$42.42M | (m) | $27.39M | (m) | -$14.00K |
|---|
| 2022-12-31 | Reported | -$10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$37.35M | (m) | (m) | (m) | (m) | (m) | (m) | $31.48M | (m) | -$5.00K |
|---|
| 2022-06-30 | Reported | (m) | -$39.06M | (m) | (m) | (m) | (m) | (m) | (m) | $30.79M | (m) | -$56.00K |
|---|
| 2022-03-31 | Reported | (m) | -$36.19M | (m) | (m) | (m) | (m) | (m) | (m) | $28.36M | (m) | -$26.00K |
|---|
| 2021-03-31 | Reported | -$38.21M | (m) | (m) | (m) | -14204.46% | $1.90M | -$37.34M | (m) | $30.73M | (m) | -$5.72M |
|---|
| 2020-12-31 | Reported | -$45.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$41.24M* | -$42.71M | $1.47M* | (m) | (m) | $4.05M* | -$39.06M* | (m) | $33.55M | (m) | -$7.87M |
|---|
| 2020-06-30 | Reported | -$38.28M* | -$39.54M | $1.27M* | (m) | (m) | $2.52M* | -$26.93M* | (m) | $31.33M | (m) | -$7.02M |
|---|
| 2020-03-31 | Reported | -$37.3M | (m) | (m) | (m) | -11036.09% | $2.64M | -$24.03M | (m) | $31.29M | (m) | -$3.70M |
|---|
| 2019-12-31 | Reported | -$41.79M | (m) | (m) | (m) | -13525.24% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$34.48M* | -$35.62M | $1.14M* | (m) | (m) | $3.78M* | -$24.49M* | (m) | $27.31M | (m) | -$4.60M |
|---|
| 2019-06-30 | Reported | -$36.66M* | -$37.20M | $541.00K* | (m) | (m) | $5.64M* | -$17.21M* | (m) | $26.17M | (m) | -$3.27M |
|---|
| 2019-03-31 | Reported | -$28.52M | (m) | (m) | (m) | -1452.04% | $7.33M | -$26.52M | (m) | $22.57M | (m) | -$3.42M |
|---|
| 2018-12-31 | Reported | (m) | -$25.01M | (m) | (m) | (m) | $4.42M | -$19.79M | (m) | $17.71M | (m) | -$2.60M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$262.25M | (m) | (m) | (m) | -347.86% | $19.04M | -$283.57M | $96.37M | $117.69M | $131.87M | $1.97M |
|---|
| 2024-12-31 | Reported | -$233.87M | (m) | (m) | (m) | -2310.99% | $22.07M | -$206.27M | $11.39M | $138.44M | $101.72M | $1.53M |
|---|
| 2023-12-31 | Reported | -$173.14M | (m) | (m) | (m) | -10196.47% | $10.99M | -$145.59M | $0.00 | $130.48M | $46.74M | -$19.00K |
|---|
| 2022-12-31 | Reported | -$135.99M | (m) | (m) | (m) | (m) | $10.84M | -$112.31M | (m) | $117.35M | (m) | $272.00K |
|---|
| 2021-12-31 | Reported | -$132.59M | (m) | (m) | (m) | (m) | $8.86M | -$117.86M | (m) | $110.84M | (m) | $58.00K |
|---|
| 2020-12-31 | Reported | -$162.49M | (m) | (m) | (m) | (m) | $14.68M | -$117.76M | (m) | $134.89M | (m) | -$24.16M |
|---|
| 2019-12-31 | Reported | -$141.45M | (m) | (m) | (m) | -4864.27% | $18.34M | -$101.48M | (m) | $105.42M | (m) | -$15.16M |
|---|
| 2019-09-30 | Rolling | (m) | -$127.99M* | (m) | (m) | (m) | $21.18M* | -$88.00M* | (m) | $93.76M* | (m) | -$13.90M* |
|---|
| 2018-09-30 | Reported | (m) | -$57.53M | (m) | (m) | (m) | $9.12M | -$31.54M | (m) | $36.15M | (m) | -$7.28M |
|---|
| 2017-09-30 | Reported | (m) | -$23.42M | (m) | (m) | (m) | $2.88M | -$16.36M | (m) | $16.01M | (m) | -$3.65M |
|---|